BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17607755)

  • 1. Paclitaxel-eluting composite fibers: drug release and tensile mechanical properties.
    Zilberman M; Kraitzer A
    J Biomed Mater Res A; 2008 Feb; 84(2):313-23. PubMed ID: 17607755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-loaded composite fibers: microstructure and emulsion stability.
    Kraitzer A; Zilberman M
    J Biomed Mater Res A; 2007 May; 81(2):427-36. PubMed ID: 17117472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel farnesylthiosalicylate (FTS)-eluting composite structures.
    Kraitzer A; Kloog Y; Zilberman M
    Eur J Pharm Sci; 2009 Jun; 37(3-4):351-62. PubMed ID: 19491026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term in vitro study of paclitaxel-eluting bioresorbable core/shell fiber structures.
    Kraitzer A; Ofek L; Schreiber R; Zilberman M
    J Control Release; 2008 Mar; 126(2):139-48. PubMed ID: 18201789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel composite fiber structures to provide drug/protein delivery for medical implants and tissue regeneration.
    Zilberman M
    Acta Biomater; 2007 Jan; 3(1):51-7. PubMed ID: 16956799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic-eluting bioresorbable composite fibers for wound healing applications: microstructure, drug delivery and mechanical properties.
    Elsner JJ; Zilberman M
    Acta Biomater; 2009 Oct; 5(8):2872-83. PubMed ID: 19416766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin-eluting bioresorbable composite fibers for wound healing applications.
    Zilberman M; Golerkansky E; Elsner JJ; Berdicevsky I
    J Biomed Mater Res A; 2009 Jun; 89(3):654-66. PubMed ID: 18442118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel bioresorbabale composite fiber structures loaded with proteins for tissue regeneration applications: microstructure and protein release.
    Levy Y; Zilberman M
    J Biomed Mater Res A; 2006 Dec; 79(4):779-87. PubMed ID: 16883584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composite fiber structures with antiproliferative agents exhibit advantageous drug delivery and cell growth inhibition in vitro.
    Kraitzer A; Kloog Y; Haklai R; Zilberman M
    J Pharm Sci; 2011 Jan; 100(1):133-49. PubMed ID: 20623695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly porous bioresorbable scaffolds with controlled release of bioactive agents for tissue-regeneration applications.
    Grinberg O; Binderman I; Bahar H; Zilberman M
    Acta Biomater; 2010 Apr; 6(4):1278-87. PubMed ID: 19887123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of acrylate-based block copolymers prepared by atom transfer radical polymerization as matrices for paclitaxel delivery from coronary stents.
    Richard RE; Schwarz M; Ranade S; Chan AK; Matyjaszewski K; Sumerlin B
    Biomacromolecules; 2005; 6(6):3410-8. PubMed ID: 16283773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release of analgesic drugs from porous bioresorbable structures for various biomedical applications.
    Shemesh M; Gilboa E; Ben-Gal TS; Zilberman M
    J Biomater Sci Polym Ed; 2014; 25(4):410-30. PubMed ID: 24313726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel.
    Jackson JK; Smith J; Letchford K; Babiuk KA; Machan L; Signore P; Hunter WL; Wang K; Burt HM
    Int J Pharm; 2004 Sep; 283(1-2):97-109. PubMed ID: 15363506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical characterization of controlled release of paclitaxel from the TAXUS Express2 drug-eluting stent.
    Ranade SV; Miller KM; Richard RE; Chan AK; Allen MJ; Helmus MN
    J Biomed Mater Res A; 2004 Dec; 71(4):625-34. PubMed ID: 15514926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly porous drug-eluting structures: from wound dressings to stents and scaffolds for tissue regeneration.
    Elsner JJ; Kraitzer A; Grinberg O; Zilberman M
    Biomatter; 2012; 2(4):239-70. PubMed ID: 23507890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-property effects of novel bioresorbable hybrid structures with controlled release of analgesic drugs for wound healing applications.
    Shemesh M; Zilberman M
    Acta Biomater; 2014 Mar; 10(3):1380-91. PubMed ID: 24316366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mathematical model for predicting controlled release of bioactive agents from composite fiber structures.
    Zilberman M; Sofer M
    J Biomed Mater Res A; 2007 Mar; 80(3):679-86. PubMed ID: 17072845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
    Richard R; Schwarz M; Chan K; Teigen N; Boden M
    J Biomed Mater Res A; 2009 Aug; 90(2):522-32. PubMed ID: 18563805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled delivery of paclitaxel from stent coatings using poly(hydroxystyrene-b-isobutylene-b-hydroxystyrene) and its acetylated derivative.
    Sipos L; Som A; Faust R; Richard R; Schwarz M; Ranade S; Boden M; Chan K
    Biomacromolecules; 2005; 6(5):2570-82. PubMed ID: 16153094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting medical implants.
    Zilberman M; Kraitzer A; Grinberg O; Elsner JJ
    Handb Exp Pharmacol; 2010; (197):299-341. PubMed ID: 20217535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.